Brind.

Charles River supports an EU-backed effort to improve access to CAR-T therapies in Europe.

1 report, 1 independent Updated Aug 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Europe Charles River Laboratories

Keep exploring

The entities involved

Europe
terrestrial continent located in north-western Eurasia
- The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
Charles River Laboratories
major US biomedical company
- Agilent Technologies and Charles River Laboratories are both companies operating in the life sciences sector.Sat 11:57
- Apollo is the digital client engagement platform for Charles River Laboratories, and Mark Mintz serves as CIO and head of global shared services.Sat 11:57

Related events

Uber is expanding its operations into the European market.Sep 2

Coverage

Newest first; wire copies grouped

Aug 26Business WireCharles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing WILMINGTON, Mass., August 26, 2025--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: